Opinion
Video
Neal Shore, MD, FACS, and Brian M. Shuch, MD, introduce themselves and discuss the growing incidence of kidney cancer, the general prognosis, and early signs and symptoms.
ALLO-316 shows encouraging CAR activity in advanced ccRCC
Casdatifan demonstrates encouraging clinical activity in renal cell carcinoma
FDA grants Regenerative Medicine Advanced Therapy designation to ALLO-316 for RCC
Pazopanib plus bevacizumab shows promising phase 2 efficacy in ccRCC
Benmelstobart plus anlotinib improves PFS, ORR vs sunitinib in aRCC
Serum glycoproteins may predict response to nivolumab/cabozantinib in aRCC